does blue cross blue shield pay for glp 1 Why we are changing coverage of GLP-1 drugs weight loss Why Blue Cross Blue Shield

Liraglutide vs Semaglutide: The Molecular Difference Liraglutide (Saxenda): First-generation GLP-1 agonist for weight loss Approximately 97% amino acid similarity to natural GLP-1 Half-life of approximately 13 hours Requires daily injection to maintain blood levels Semaglutide (Ozempic, Wegovy): Second-generation GLP-1 agonist Modified structure for greater potency and longer action Half-life of approximately 7 days Weekly injection maintains stable blood levels The structural modifications in semaglutide make it bind more effectively to GLP-1 receptors and resist breakdown longer

Markets that treat affordability thresholds as strategic levers, not afterthoughts, will own the volume growth phase of global GLP-1 adoption

A helpful framework comes from insulin titration

Weight loss is broadly viewed as positive, with leaner and smaller body sizes generally being more aligned with westernized body norms

At the same time, they reduce appetite by interacting with hunger signals in the brain, leading to significant weight loss

ACS Appl Mater Interfaces